期刊文献+

A群链球菌四价重组蛋白的表达、纯化及其免疫原性 被引量:1

Expression,Purification and Immunogenicity of Tetravalent Recombinant Group A Streptococcus Protein
原文传递
导出
摘要 目的原核表达并纯化A群链球菌M1、3、6、18型四价重组蛋白,并检测其免疫原性。方法以克隆质粒pUC18-Strep4为模板,PCR法扩增四价重组蛋白基因,克隆至表达载体pQE30中,构建重组表达质粒,转化E.coilM15,筛选阳性克隆,IPTG诱导表达。采用Ni2+-NTA凝胶亲和层析纯化重组蛋白。以该蛋白免疫家兔,ELISA法检测血清抗体滴度;间接免疫荧光法(IFA)检测A群链球菌型特异性抗体;体外杀菌试验检测杀菌抗体活性。结果四价重组蛋白表达质粒pQE30-Strep4经双酶切和测序,证明构建正确。重组蛋白相对分子质量与预期相符,表达量约占菌体总蛋白的30%,为可溶性表达。纯化后蛋白纯度可达90%以上,并可诱导家兔产生高滴度的M1、3、6型特异性杀菌抗体。结论已成功表达了A群链球菌四价重组蛋白,纯化后的蛋白可诱导家兔产生针对A群链球菌M1、3、6三个血清型菌株的特异性杀菌抗体。 Objective To express tetravalent recombinant protein against group A streptococcus(GAS)of serotypes M1,3,6 and 18 in prokaryotic cells,purify the expressed product and determine its immunogenicity.Methods The target gene was amplified by PCR using cloning vector pUC18-Strep4 as a template and cloned into expression vector pQE30.The constructed recombinant plasmid was transformed to E.coli M15,and positive clones were screened for expression under induction of IPTG.The expressed recombinant protein was purified by Ni^2+-NTA gel affinity chromatography.Rabbits were immunized with the expressed protein,and their serum antibody titers were determined by ELISA.The type-specific antibodies against M1,M3,M6 and M18 of GAS were determined by IFA,and serum bactericidal antibody activity by in vitro bactericidal test.Results Restriction analysis and sequencing proved that recombinant plasmid pQE30-Strep4 was constructed correctly.The expressed product in a soluble form,with a relative molecular mass consistent with that expected,contained about 30% of total somatic protein and reached a purity of more than 90%.Specific bactericidal antibody titers against serotypes M1,3 and 6 of GAS were induced in rabbits.Conclusion The tetravalent recombinant protein against GAS of serotypes M1,3,6 and 18 was successfully expressed.The purified recombinant protein induced specific bactericidal antibodies against serotypes M1,3 and 6 of GAS.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第1期17-21,共5页 Chinese Journal of Biologicals
关键词 A群链球菌 重组蛋白 原核表达 免疫原性 Group A streptococcus (GAS) Recombinant protein Prokaryotic expression Immunogenicity
  • 相关文献

参考文献11

  • 1McArthur JD, Walker MJ. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development. Molecular Microbiol, 2006, 59 ( 1 ): 1-4.
  • 2Dale JB. Multivalent group A streptococcal vaccines. Infect Dis Clin North Am, 1999, 13 (1): 227-243.
  • 3Kotloff KL, Corretti M, Palmer K, et al. Safety and irnmunogenieity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase I trial. JAMA, 2004, 292 (6): 709-715.
  • 4McNeil SA, Halperin SA, Langley JM, et al. A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults. International Congress Series 1289, 2006: 303-306.
  • 5喻刚,杨京生,全家妩.四价重组A群链球菌多肽疫苗基因序列的合成及克隆[J].中国生物制品学杂志,2009,22(5):474-479. 被引量:1
  • 6Batzloff MR, Hayman WA, Davies MR, et al. Protection against group A streptococcus by immunization with JS-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis. 2003, 187 ( 10): 1598 -1608.
  • 7樊景凤,李光,王斌,马成,梁玉波.间接免疫荧光抗体技术检测凡纳滨对虾红体病病原——副溶血弧菌[J].海洋环境科学,2007,26(6):501-503. 被引量:14
  • 8Dale JB. Muhivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine, 1999, 17 (2): 193-200.
  • 9Hu MC, Walls MA, Stroop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immu, 2002, 70 (4): 2171- 2177.
  • 10Yoonim N, Olive C, Pruksachatkunakorn C, et al. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. BMC Microbiol, 2006, 6 ( 8 ): 71-77.

二级参考文献26

  • 1陈志红,龚守芳,董太明,苏健,吴红穗,陈剑光,朱振宇.应用emm基因序列分析对104株A群链球菌分型[J].中华微生物学和免疫学杂志,2004,24(6):489-491. 被引量:13
  • 2付崇罗,宋微波,李,张永忠,闫华超.栉孔扇贝感染急性病毒性坏死症病毒的组织病理学与免疫荧光检测[J].微生物学报,2004,44(6):741-744. 被引量:14
  • 3章辉,朱荫昌.B细胞表位预测的研究进展[J].中国血吸虫病防治杂志,2006,18(3):236-238. 被引量:9
  • 4孙颖杰,孙延峰,潘凤城,苏永生.猪生殖和呼吸综合征间接免疫荧光抗体试验诊断技术的研究[J].中国兽医科技,1997,27(3):3-5. 被引量:14
  • 5黄震东.我国风湿热流行状况及预防策略//吴锡仕,顺东风.预防心脏病学.济南:山东科技出版社,2001:396-417.
  • 6Dale JB, Simmons M, Chiang EC, et al. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine, 1996, 14( 10): 944-948.
  • 7Hu MC, Walls MA, Steoop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immu, 2002, 70 (4): 2171- 2177.
  • 8Richard E, Goodman. Practical and predictive bioinformatics methods for the identification of potentially cross-reactive protein matches. Mol Nutr Food Res, 2006, 50(7): 655-660.
  • 9Hayman WA, Brandt ER, Relf WA, et al. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol, 1997, 9( 11 ): 1723-1733.
  • 10Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev, 2000, 13 (3):470-511.

共引文献13

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部